Even though, the inverse correlation of colonic CD39+ ILC3 numbers and the intestinal inflammation severity indicates that CD39 expression on ILC3s may be potentially used as a biomarker for the IBD severity. The gene discussed is ENTPD1; the disease is inflammatory bowel disease.